The phosphorylation and dephosphorylation of proteins on serine and threonine residues is an essential means of regulating a broad range of cellular functions in eukaryotes, including cell division, homeostasis and apoptosis. The serine/threonine (Ser/Thr) protein kinases are a group of proteins that are intimately involved in this process. MARK4 (MAP/microtubule affinity-regulating kinase 4), also known as MARKL1 or KIAA1860, is a 752 amino acid protein that contains one UBA domain, one protein kinase domain and one kinase-associated domain and belongs to the Ser/Thr protein kinase family. Expressed ubiquitously as two alternatively spliced isoforms, one of which is brain-specific, MARK4 uses ATP to catalyze the phosphorylation of target proteins and is thought to be involved in cell growth. MARK4 is upregulated in hepatocellular carcinoma cells, suggesting a role for MARK4 in tumorigenesis.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of MARK4 of mouse, rat and human origin by WB, IP, IF and ELISA also reactive with additional species, including canine
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 628-752 mapping at the C-terminus of MARK4 of human origin
Tissue Specificity
epitope corresponding to amino acids 628-752 mapping at the C-terminus of MARK4 of human origin